CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 18,217 shares at $0.69 ($12,570)
- 4 Open-market sale Chief Executive Officer sold 18,681 shares at $0.69 ($12,890)
- 4 Open-market sale Chief Executive Officer sold 19,388 shares at $0.70 ($13,572)
- 4 Open-market sale Chief Executive Officer sold 36,762 shares at $0.70 ($25,733)
- 4 Open-market sale Chief Medical Officer sold 26,238 shares at $0.70 ($18,367)
- 4 Open-market sale Chief Executive Officer sold 21,275 shares at $0.70 ($14,893)
- 4/A Grant or award Director acquired 64,656 shares (grant or award)
- 4/A Grant or award Director acquired 43,104 shares (grant or award)
- 4/A Grant or award Director acquired 21,552 shares (grant or award)
- 4 Grant or award Director acquired 43,104 shares (grant or award)
- 4 Grant or award Director acquired 64,656 shares (grant or award)
- 4 Grant or award Director acquired 21,552 shares (grant or award)
- 4/A Grant or award Chief Financial Officer acquired 1,270,000 shares (grant or award)
- 4 Open-market sale Chief Medical Officer sold 9,555 shares at $0.82 ($7,835)
- 4 Open-market sale Chief Executive Officer sold 18,415 shares at $0.77 ($14,180)
- 4 Open-market sale Chief Medical Officer sold 8,242 shares at $0.77 ($6,346)
- 4 Other acquisition Director acquired 67,678 shares (other)
- 4 Grant or award Chief Financial Officer acquired 1,270,000 shares (grant or award)
Page 8 of 10 · 186 filings